ArticleMolecular cancer2025
CircRNF10 sequestrates β-catenin by a dual regulatory circuit of direct degradation and a miR-1275/DKK3-mediated inhibition in driver gene- negative lung adenocarcinoma.
Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCircular RNAs (circRNAs) exert critical regulatory functions in tumor biology by modulating pathways associated with oncogenesis or tumor suppression. Despite substantial progress in elucidating their roles in several malignancies, the contribution of circRNAs to the pathogenesis of driver gene-negative lung adenocarcinoma (LUAD), a molecular subtype lacking actionable genetic alterations and exhibiting limited response to existing targeted or immunotherapeutic strategies, remains poorly defined.
methodsThe expression of circRNF10 in driver gene-negative LUAD was analyzed using circRNA microarray analysis followed by RT-qPCR validation. A series of functional assays were performed both in vitro and in vivo to evaluate the effects of circRNF10 on tumor cell behavior, including proliferation (EdU incorporation), migration (wound healing), and invasion (transwell assays), as well as tumor growth in a murine model. To elucidate the underlying molecular mechanism, we employed a combination of computational and experimental approaches, including AlphaFold3-based structural prediction, in vitro transcription, biotin-labeled RNA pulldown, RNA immunoprecipitation (RIP), and dual-luciferase reporter assays.
resultsIn this study, we identified a previously uncharacterized circular RNA, circRNF10, which is markedly downregulated in driver gene-negative lung adenocarcinoma (LUAD) and positively associated with favorable clinical outcomes. Functional analyses revealed that circRNF10 overexpression suppresses LUAD cell proliferation, migration, and invasion in vitro and in vivo, primarily through inhibition of the Wnt/β-catenin signaling pathway. Mechanistically, circRNF10 directly interacts with β-catenin via its cyclization site, thereby promoting β-catenin degradation. Moreover, circRNF10 functions as a competing endogenous RNA by sequestering miR-1275, thereby alleviating the miR-1275-mediated suppression of DKK3, a potent inhibitor of the Wnt pathway. Our findings further confirm that circRNF10 promotes β-catenin degradation through direct interaction and modulation of the miR-1275/DKK3 signaling cascade.
conclusionsCollectively, our findings highlight circRNF10 as a tumor suppressor in driver gene-negative LUAD and suggest that restoring circRNF10 expression represents a promising therapeutic approach for this refractory subtype.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.